Occurrence of other tumors in patients with GIST

Abstract Objective Evaluate the presence of other tumors in cohort of patients with GIST treated at a cancer treatment referral center – INCA. Methods We reviewed the medical records of patients diagnosed with GIST who were treated at INCA between 1998 and 2008. Immunohistological diagnosis was conf...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Surgical oncology 2010-12, Vol.19 (4), p.e140-e143
Hauptverfasser: Gonçalves, Rinaldo, Linhares, Eduardo, Albagli, Rafael, Valadão, Marcus, Vilhena, Bruno, Romano, Sérgio, Ferreira, Carlos Gil
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page e143
container_issue 4
container_start_page e140
container_title Surgical oncology
container_volume 19
creator Gonçalves, Rinaldo
Linhares, Eduardo
Albagli, Rafael
Valadão, Marcus
Vilhena, Bruno
Romano, Sérgio
Ferreira, Carlos Gil
description Abstract Objective Evaluate the presence of other tumors in cohort of patients with GIST treated at a cancer treatment referral center – INCA. Methods We reviewed the medical records of patients diagnosed with GIST who were treated at INCA between 1998 and 2008. Immunohistological diagnosis was confirmed by a pathologist specialized in sarcomas. Patients presenting second non-GIST tumors were identified. Age, sex, tumor location, risk groups (according to the National Institutes of Health criteria), characteristics of non-GIST tumors and treatment results were analyzed. Results Among the 101 patients diagnosed with GIST who were evaluated during the study period, 14 (13.8%) had other non-GIST tumors, 9 females (64.3%), with a median age of 68 years (10–79 years). The stomach was the location of GISTs in 8 cases (57.1%), followed by the small bowel in 4 cases (28.5%), colon and mesentery with 1 case (7.1%) each. The mean size of lesions was 4.79 cm (0.3–15 cm), with malignant potential low/very low in 7 cases (50%), intermediate in 5 cases (35.7%) and high in 2 cases (14.3%). The diagnosis of GIST was incidental in 6 cases and in one case the non-GIST tumor was incidental. The non-GIST tumors were most frequent in the stomach (adenocarcinoma), in 4 cases (28.5%) and colon/rectum (adenocarcinoma) in 4 other cases. The other sites involved were breast (ductal carcinoma), kidney (clear cell carcinoma), prostate (adenocarcinoma), endometrium (adenocarcinoma), ovary (adenocarcinoma) and adrenal (neuroblastoma), with one case each. The tumors were synchronous in 7 cases (50%). With a median follow-up after GIST resection of 41 months (2–87 months), 9 patients were alive without evidence of disease, 2 died due to GIST, 2 died due to non-GIST tumors and the remaining patient died due to postoperative complications. Conclusions We discovered a 13.8% incidence of non-GIST tumors in a series of 101 GIST cases under our care. This association should always be considered in the management of patients with GIST.
doi_str_mv 10.1016/j.suronc.2010.06.004
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_757464273</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0960740410000617</els_id><sourcerecordid>757464273</sourcerecordid><originalsourceid>FETCH-LOGICAL-c444t-c19c58c4c73dc6ad20d65ddd39606319b40e8c3629c77620c2db54ec7402a4033</originalsourceid><addsrcrecordid>eNqFkU1rGzEQhkVJqB0n_6CUhRx6Wnf0sZL3UiihTQwBH5KcxXo0xnLWK1faTcm_rxa7KeTSk4R4ZvTOM4x94jDnwPXX3TwNMXQ4F5CfQM8B1Ac25QtTl1IKOGNTqDWURoGasIuUdgCgjeAf2UTkS8UFnzJYIQ4xUodUhE0R-i3Foh_2IabCd8Wh6T11fSp--35b3C4fHi_Z-aZpE12dzhl7-vnj8eauvF_dLm--35eolOpL5DVWC1RopEPdOAFOV845mSNpyeu1Alqg1KJGY7QAFG5dKcKcVjQKpJyxL8e-hxh-DZR6u_cJqW2bjsKQrKmM0kqYkbx-R-7CELscznKQVbUAVUOm1JHCGFKKtLGH6PdNfM2QHYXanT0KtaNQC9pmobns86n5sN6Teyv6azAD344AZRkvnqJN6EedzkfC3rrg__fD-wbY-s5j0z7TK6V_s9gkLNiHcanjTjmM--RG_gHgD5qs</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1035580490</pqid></control><display><type>article</type><title>Occurrence of other tumors in patients with GIST</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Gonçalves, Rinaldo ; Linhares, Eduardo ; Albagli, Rafael ; Valadão, Marcus ; Vilhena, Bruno ; Romano, Sérgio ; Ferreira, Carlos Gil</creator><creatorcontrib>Gonçalves, Rinaldo ; Linhares, Eduardo ; Albagli, Rafael ; Valadão, Marcus ; Vilhena, Bruno ; Romano, Sérgio ; Ferreira, Carlos Gil</creatorcontrib><description>Abstract Objective Evaluate the presence of other tumors in cohort of patients with GIST treated at a cancer treatment referral center – INCA. Methods We reviewed the medical records of patients diagnosed with GIST who were treated at INCA between 1998 and 2008. Immunohistological diagnosis was confirmed by a pathologist specialized in sarcomas. Patients presenting second non-GIST tumors were identified. Age, sex, tumor location, risk groups (according to the National Institutes of Health criteria), characteristics of non-GIST tumors and treatment results were analyzed. Results Among the 101 patients diagnosed with GIST who were evaluated during the study period, 14 (13.8%) had other non-GIST tumors, 9 females (64.3%), with a median age of 68 years (10–79 years). The stomach was the location of GISTs in 8 cases (57.1%), followed by the small bowel in 4 cases (28.5%), colon and mesentery with 1 case (7.1%) each. The mean size of lesions was 4.79 cm (0.3–15 cm), with malignant potential low/very low in 7 cases (50%), intermediate in 5 cases (35.7%) and high in 2 cases (14.3%). The diagnosis of GIST was incidental in 6 cases and in one case the non-GIST tumor was incidental. The non-GIST tumors were most frequent in the stomach (adenocarcinoma), in 4 cases (28.5%) and colon/rectum (adenocarcinoma) in 4 other cases. The other sites involved were breast (ductal carcinoma), kidney (clear cell carcinoma), prostate (adenocarcinoma), endometrium (adenocarcinoma), ovary (adenocarcinoma) and adrenal (neuroblastoma), with one case each. The tumors were synchronous in 7 cases (50%). With a median follow-up after GIST resection of 41 months (2–87 months), 9 patients were alive without evidence of disease, 2 died due to GIST, 2 died due to non-GIST tumors and the remaining patient died due to postoperative complications. Conclusions We discovered a 13.8% incidence of non-GIST tumors in a series of 101 GIST cases under our care. This association should always be considered in the management of patients with GIST.</description><identifier>ISSN: 0960-7404</identifier><identifier>EISSN: 1879-3320</identifier><identifier>DOI: 10.1016/j.suronc.2010.06.004</identifier><identifier>PMID: 20675121</identifier><language>eng</language><publisher>Netherlands: Elsevier Ltd</publisher><subject>Adenocarcinoma ; Adenocarcinoma - epidemiology ; Aged ; Brazil - epidemiology ; Breast cancer ; Child ; Colonic Neoplasms - epidemiology ; Female ; Follow-Up Studies ; Gastrointestinal Stromal Tumors - epidemiology ; Gastrointestinal Stromal Tumors - surgery ; GIST ; Hematology, Oncology and Palliative Medicine ; Humans ; Incidence ; Incidental ; Male ; Mesenchymal ; Metachronous ; Middle Aged ; Mutation ; Neoplasms, Multiple Primary - epidemiology ; Rectal Neoplasms - epidemiology ; Retrospective Studies ; Stomach Neoplasms - epidemiology ; Studies ; Surgery ; Synchronous ; Tumors ; Young Adult</subject><ispartof>Surgical oncology, 2010-12, Vol.19 (4), p.e140-e143</ispartof><rights>Elsevier Ltd</rights><rights>2010 Elsevier Ltd</rights><rights>Copyright © 2010 Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c444t-c19c58c4c73dc6ad20d65ddd39606319b40e8c3629c77620c2db54ec7402a4033</citedby><cites>FETCH-LOGICAL-c444t-c19c58c4c73dc6ad20d65ddd39606319b40e8c3629c77620c2db54ec7402a4033</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.suronc.2010.06.004$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,778,782,3539,27907,27908,45978</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20675121$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Gonçalves, Rinaldo</creatorcontrib><creatorcontrib>Linhares, Eduardo</creatorcontrib><creatorcontrib>Albagli, Rafael</creatorcontrib><creatorcontrib>Valadão, Marcus</creatorcontrib><creatorcontrib>Vilhena, Bruno</creatorcontrib><creatorcontrib>Romano, Sérgio</creatorcontrib><creatorcontrib>Ferreira, Carlos Gil</creatorcontrib><title>Occurrence of other tumors in patients with GIST</title><title>Surgical oncology</title><addtitle>Surg Oncol</addtitle><description>Abstract Objective Evaluate the presence of other tumors in cohort of patients with GIST treated at a cancer treatment referral center – INCA. Methods We reviewed the medical records of patients diagnosed with GIST who were treated at INCA between 1998 and 2008. Immunohistological diagnosis was confirmed by a pathologist specialized in sarcomas. Patients presenting second non-GIST tumors were identified. Age, sex, tumor location, risk groups (according to the National Institutes of Health criteria), characteristics of non-GIST tumors and treatment results were analyzed. Results Among the 101 patients diagnosed with GIST who were evaluated during the study period, 14 (13.8%) had other non-GIST tumors, 9 females (64.3%), with a median age of 68 years (10–79 years). The stomach was the location of GISTs in 8 cases (57.1%), followed by the small bowel in 4 cases (28.5%), colon and mesentery with 1 case (7.1%) each. The mean size of lesions was 4.79 cm (0.3–15 cm), with malignant potential low/very low in 7 cases (50%), intermediate in 5 cases (35.7%) and high in 2 cases (14.3%). The diagnosis of GIST was incidental in 6 cases and in one case the non-GIST tumor was incidental. The non-GIST tumors were most frequent in the stomach (adenocarcinoma), in 4 cases (28.5%) and colon/rectum (adenocarcinoma) in 4 other cases. The other sites involved were breast (ductal carcinoma), kidney (clear cell carcinoma), prostate (adenocarcinoma), endometrium (adenocarcinoma), ovary (adenocarcinoma) and adrenal (neuroblastoma), with one case each. The tumors were synchronous in 7 cases (50%). With a median follow-up after GIST resection of 41 months (2–87 months), 9 patients were alive without evidence of disease, 2 died due to GIST, 2 died due to non-GIST tumors and the remaining patient died due to postoperative complications. Conclusions We discovered a 13.8% incidence of non-GIST tumors in a series of 101 GIST cases under our care. This association should always be considered in the management of patients with GIST.</description><subject>Adenocarcinoma</subject><subject>Adenocarcinoma - epidemiology</subject><subject>Aged</subject><subject>Brazil - epidemiology</subject><subject>Breast cancer</subject><subject>Child</subject><subject>Colonic Neoplasms - epidemiology</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Gastrointestinal Stromal Tumors - epidemiology</subject><subject>Gastrointestinal Stromal Tumors - surgery</subject><subject>GIST</subject><subject>Hematology, Oncology and Palliative Medicine</subject><subject>Humans</subject><subject>Incidence</subject><subject>Incidental</subject><subject>Male</subject><subject>Mesenchymal</subject><subject>Metachronous</subject><subject>Middle Aged</subject><subject>Mutation</subject><subject>Neoplasms, Multiple Primary - epidemiology</subject><subject>Rectal Neoplasms - epidemiology</subject><subject>Retrospective Studies</subject><subject>Stomach Neoplasms - epidemiology</subject><subject>Studies</subject><subject>Surgery</subject><subject>Synchronous</subject><subject>Tumors</subject><subject>Young Adult</subject><issn>0960-7404</issn><issn>1879-3320</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkU1rGzEQhkVJqB0n_6CUhRx6Wnf0sZL3UiihTQwBH5KcxXo0xnLWK1faTcm_rxa7KeTSk4R4ZvTOM4x94jDnwPXX3TwNMXQ4F5CfQM8B1Ac25QtTl1IKOGNTqDWURoGasIuUdgCgjeAf2UTkS8UFnzJYIQ4xUodUhE0R-i3Foh_2IabCd8Wh6T11fSp--35b3C4fHi_Z-aZpE12dzhl7-vnj8eauvF_dLm--35eolOpL5DVWC1RopEPdOAFOV845mSNpyeu1Alqg1KJGY7QAFG5dKcKcVjQKpJyxL8e-hxh-DZR6u_cJqW2bjsKQrKmM0kqYkbx-R-7CELscznKQVbUAVUOm1JHCGFKKtLGH6PdNfM2QHYXanT0KtaNQC9pmobns86n5sN6Teyv6azAD344AZRkvnqJN6EedzkfC3rrg__fD-wbY-s5j0z7TK6V_s9gkLNiHcanjTjmM--RG_gHgD5qs</recordid><startdate>20101201</startdate><enddate>20101201</enddate><creator>Gonçalves, Rinaldo</creator><creator>Linhares, Eduardo</creator><creator>Albagli, Rafael</creator><creator>Valadão, Marcus</creator><creator>Vilhena, Bruno</creator><creator>Romano, Sérgio</creator><creator>Ferreira, Carlos Gil</creator><general>Elsevier Ltd</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>8FD</scope><scope>FR3</scope><scope>K9.</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>20101201</creationdate><title>Occurrence of other tumors in patients with GIST</title><author>Gonçalves, Rinaldo ; Linhares, Eduardo ; Albagli, Rafael ; Valadão, Marcus ; Vilhena, Bruno ; Romano, Sérgio ; Ferreira, Carlos Gil</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c444t-c19c58c4c73dc6ad20d65ddd39606319b40e8c3629c77620c2db54ec7402a4033</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Adenocarcinoma</topic><topic>Adenocarcinoma - epidemiology</topic><topic>Aged</topic><topic>Brazil - epidemiology</topic><topic>Breast cancer</topic><topic>Child</topic><topic>Colonic Neoplasms - epidemiology</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Gastrointestinal Stromal Tumors - epidemiology</topic><topic>Gastrointestinal Stromal Tumors - surgery</topic><topic>GIST</topic><topic>Hematology, Oncology and Palliative Medicine</topic><topic>Humans</topic><topic>Incidence</topic><topic>Incidental</topic><topic>Male</topic><topic>Mesenchymal</topic><topic>Metachronous</topic><topic>Middle Aged</topic><topic>Mutation</topic><topic>Neoplasms, Multiple Primary - epidemiology</topic><topic>Rectal Neoplasms - epidemiology</topic><topic>Retrospective Studies</topic><topic>Stomach Neoplasms - epidemiology</topic><topic>Studies</topic><topic>Surgery</topic><topic>Synchronous</topic><topic>Tumors</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gonçalves, Rinaldo</creatorcontrib><creatorcontrib>Linhares, Eduardo</creatorcontrib><creatorcontrib>Albagli, Rafael</creatorcontrib><creatorcontrib>Valadão, Marcus</creatorcontrib><creatorcontrib>Vilhena, Bruno</creatorcontrib><creatorcontrib>Romano, Sérgio</creatorcontrib><creatorcontrib>Ferreira, Carlos Gil</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Surgical oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gonçalves, Rinaldo</au><au>Linhares, Eduardo</au><au>Albagli, Rafael</au><au>Valadão, Marcus</au><au>Vilhena, Bruno</au><au>Romano, Sérgio</au><au>Ferreira, Carlos Gil</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Occurrence of other tumors in patients with GIST</atitle><jtitle>Surgical oncology</jtitle><addtitle>Surg Oncol</addtitle><date>2010-12-01</date><risdate>2010</risdate><volume>19</volume><issue>4</issue><spage>e140</spage><epage>e143</epage><pages>e140-e143</pages><issn>0960-7404</issn><eissn>1879-3320</eissn><abstract>Abstract Objective Evaluate the presence of other tumors in cohort of patients with GIST treated at a cancer treatment referral center – INCA. Methods We reviewed the medical records of patients diagnosed with GIST who were treated at INCA between 1998 and 2008. Immunohistological diagnosis was confirmed by a pathologist specialized in sarcomas. Patients presenting second non-GIST tumors were identified. Age, sex, tumor location, risk groups (according to the National Institutes of Health criteria), characteristics of non-GIST tumors and treatment results were analyzed. Results Among the 101 patients diagnosed with GIST who were evaluated during the study period, 14 (13.8%) had other non-GIST tumors, 9 females (64.3%), with a median age of 68 years (10–79 years). The stomach was the location of GISTs in 8 cases (57.1%), followed by the small bowel in 4 cases (28.5%), colon and mesentery with 1 case (7.1%) each. The mean size of lesions was 4.79 cm (0.3–15 cm), with malignant potential low/very low in 7 cases (50%), intermediate in 5 cases (35.7%) and high in 2 cases (14.3%). The diagnosis of GIST was incidental in 6 cases and in one case the non-GIST tumor was incidental. The non-GIST tumors were most frequent in the stomach (adenocarcinoma), in 4 cases (28.5%) and colon/rectum (adenocarcinoma) in 4 other cases. The other sites involved were breast (ductal carcinoma), kidney (clear cell carcinoma), prostate (adenocarcinoma), endometrium (adenocarcinoma), ovary (adenocarcinoma) and adrenal (neuroblastoma), with one case each. The tumors were synchronous in 7 cases (50%). With a median follow-up after GIST resection of 41 months (2–87 months), 9 patients were alive without evidence of disease, 2 died due to GIST, 2 died due to non-GIST tumors and the remaining patient died due to postoperative complications. Conclusions We discovered a 13.8% incidence of non-GIST tumors in a series of 101 GIST cases under our care. This association should always be considered in the management of patients with GIST.</abstract><cop>Netherlands</cop><pub>Elsevier Ltd</pub><pmid>20675121</pmid><doi>10.1016/j.suronc.2010.06.004</doi></addata></record>
fulltext fulltext
identifier ISSN: 0960-7404
ispartof Surgical oncology, 2010-12, Vol.19 (4), p.e140-e143
issn 0960-7404
1879-3320
language eng
recordid cdi_proquest_miscellaneous_757464273
source MEDLINE; Elsevier ScienceDirect Journals
subjects Adenocarcinoma
Adenocarcinoma - epidemiology
Aged
Brazil - epidemiology
Breast cancer
Child
Colonic Neoplasms - epidemiology
Female
Follow-Up Studies
Gastrointestinal Stromal Tumors - epidemiology
Gastrointestinal Stromal Tumors - surgery
GIST
Hematology, Oncology and Palliative Medicine
Humans
Incidence
Incidental
Male
Mesenchymal
Metachronous
Middle Aged
Mutation
Neoplasms, Multiple Primary - epidemiology
Rectal Neoplasms - epidemiology
Retrospective Studies
Stomach Neoplasms - epidemiology
Studies
Surgery
Synchronous
Tumors
Young Adult
title Occurrence of other tumors in patients with GIST
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T18%3A21%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Occurrence%20of%20other%20tumors%20in%20patients%20with%20GIST&rft.jtitle=Surgical%20oncology&rft.au=Gon%C3%A7alves,%20Rinaldo&rft.date=2010-12-01&rft.volume=19&rft.issue=4&rft.spage=e140&rft.epage=e143&rft.pages=e140-e143&rft.issn=0960-7404&rft.eissn=1879-3320&rft_id=info:doi/10.1016/j.suronc.2010.06.004&rft_dat=%3Cproquest_cross%3E757464273%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1035580490&rft_id=info:pmid/20675121&rft_els_id=1_s2_0_S0960740410000617&rfr_iscdi=true